Van Lanschot Kempen Logo
Search
Van Lanschot Kempen Logo
Search

Transactions 2022

Dec 2022
gensight
Sole Financial Adviser
€ 12.0 million
Convertible Note Issuance
Right Arrow in Circle
Dec 2022
hansa
Joint Global Coordinator & Joint Bookrunner
SEK 416 million
PIPE
Right Arrow in Circle
Dec 2022
nsi
Sole Financial Adviser
€50 million
Term Loan Extension
Right Arrow in Circle
Dec 2022
synact pharma
Joint Global Coordinator & Joint Bookrunner
SEK 80 million
Directed Share Issue via PIPE
Right Arrow in Circle
Dec 2022
synact pharma
Sole Financial Adviser
SEK 191 million
Acquisition of TXP Pharma
Right Arrow in Circle
Dec 2022
vicore pharma
Joint Bookrunner
SEK 200 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Dec 2022
biovica
Joint Bookrunner
SEK 148 million
Guaranteed Rights Issue
Right Arrow in Circle
Dec 2022
catena
Joint Global Coordinator & Joint Bookrunner
SEK 1,642 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Dec 2022
molecular partners
Sole Block Placing Agent
1.3 million shares
Block Trade in Molecular Partner Shares
Right Arrow in Circle
Nov 2022
gensight
Sole Financial Adviser
€ 35.0 million
Secures a credit facility from the European Investment Bank
Right Arrow in Circle
Nov 2022
izicap
Sole Financial Adviser
€ 15.0 million
Secures venture debt funding from the European Investment Bank
Right Arrow in Circle
Oct 2022
brane
Joint Global Coordinator & Joint Bookrunner
SEK 170 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Oct 2022
wdp
Joint Global Coordinator & Joint Bookrunner
€ 300 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Oct 2022
zealand
Co-Lead Manager
DKK 786 million
Accelerated Bookbuild Offering
Right Arrow in Circle
Sep 2022
great grey investments
Sole Financial Adviser
Development Financing for The Ensemble
Right Arrow in Circle
Sep 2022
wdp
Joint Bookrunner
€ 61.5 million
Sale of existing shares via club deal
Right Arrow in Circle
Sep 2022
HAL Investments
Sole Financial Broker
€ 4,332 million
The acquisition of all Boskalis issued and outstanding shares
Right Arrow in Circle
Sep 2022
vastned
Sole Financial Adviser
€ 200 million
Extension of Credit Facilities
Right Arrow in Circle
Aug 2022
mendus
Sole Financial Adviser
SEK 250 million
Convertible Bonds & Shareholder commitment
Right Arrow in Circle
Aug 2022
Sanquin Health Solutions
Sole Financial Advisor
Sanquin Health Solutions selling its reagents branch to the Dutch Gilde Healthcare
Right Arrow in Circle
Jul 2022
Amvest
Sole Financial Adviser
€ 450 million
Sustainability Linked Unsecured Revolving Credit Facility
Right Arrow in Circle
Jul 2022
BioInvent
Joint Global Coordinator
SEK 299 milion
Directed share issue via club deal
Right Arrow in Circle
Jul 2022
Citymall Almere July 2022
Sole Financial Adviser
€ 156 million
Acquisition of Almere Centrum
Right Arrow in Circle
Jun 2022
abliva
Sole Global Coordinator
SEK 200 million
PIPE Rights Issue
Right Arrow in Circle
Jun 2022
aedifica
Joint Global Coordinator & Joint Bookrunner
€ 254 million
Accelerated Bookbuild Offering
Right Arrow in Circle
May 2022
synact pharma
Joint Global Coordinator & Joint Bookrunner
SEK 150 million
Rights Issue
Right Arrow in Circle
Mar 2022
graydon
Sole Financial Adviser
Undisclosed
Sale to Creditsafe
Right Arrow in Circle
Mar 2022
catena
Financial Adviser
SEK 2.17 billion
Directed Share Issue to WDP
Right Arrow in Circle
Mar 2022
innosign
Sole Financial Adviser
Capital Increase & Spin-Out
Right Arrow in Circle
Mar 2022
argenx
Co-Manager
USD 700 million
Global Accelerated Bookbuild Offering
Right Arrow in Circle
Feb 2022
ctp
Sole Financial Adviser
€ 1,226 million
Public takeover of Deutsche Industrie REIT-AG
Right Arrow in Circle
Jan 2022
aquila capital
Sole Financial Adviser
€ 330 million
Non-listed equity raise of European Logistics Fund
Right Arrow in Circle
Jan 2022
molecular partners
Sole Block Placing Agent
1.4m shares
Block Trade in Molecular Partners Shares
Right Arrow in Circle
Jan 2022
das
Sole Financial Adviser
Sale of Cannock-EDR Holding B.V.
Right Arrow in Circle